Bumpus Namandje — insider trades

Stock trades Bumpus Namandje reported on SEC Form 4 at RXRX RECURSION PHARMACEUTICALS, INC..

• Jun 18, 2026: sold 3,963 shares of RXRX RECURSION PHARMACEUTICALS, INC. ($12.6K)
• Jun 3, 2026: sold 4,386 shares of RXRX RECURSION PHARMACEUTICALS, INC. ($15.5K)